290 related articles for article (PubMed ID: 35216409)
1. GnRH Analogues as a Co-Treatment to Therapy in Women of Reproductive Age with Cancer and Fertility Preservation.
Valsamakis G; Valtetsiotis K; Charmandari E; Lambrinoudaki I; Vlahos NF
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216409
[TBL] [Abstract][Full Text] [Related]
2. Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?
Hasky N; Uri-Belapolsky S; Goldberg K; Miller I; Grossman H; Stemmer SM; Ben-Aharon I; Shalgi R
Hum Reprod; 2015 May; 30(5):1089-101. PubMed ID: 25796551
[TBL] [Abstract][Full Text] [Related]
3. [Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial].
Gris-Martínez JM; Trillo-Urrutia L; Gómez-Cabeza JJ; Encabo-Duró G
Med Clin (Barc); 2016 Feb; 146(3):97-103. PubMed ID: 26194532
[TBL] [Abstract][Full Text] [Related]
4. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
[TBL] [Abstract][Full Text] [Related]
5. 'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservation.
Blumenfeld Z; Katz G; Evron A
Ann Oncol; 2014 Sep; 25(9):1719-1728. PubMed ID: 24651411
[TBL] [Abstract][Full Text] [Related]
6. Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.
Blumenfeld Z; Evron A
Expert Opin Pharmacother; 2015 May; 16(7):1009-20. PubMed ID: 25826240
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic ovarian preservation in young women undergoing chemotherapy.
Chahvar ST; Al-Shawaf T; Tranquilli AL
Curr Med Chem; 2014; 21(2):223-9. PubMed ID: 24164203
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women.
Chen H; Xiao L; Li J; Cui L; Huang W
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008018. PubMed ID: 30827035
[TBL] [Abstract][Full Text] [Related]
9. Both in vivo FSH depletion and follicular exposure to Gonadotrophin-releasing hormone analogues in vitro are not effective to prevent follicular depletion during chemotherapy in mice.
Horicks F; Van Den Steen G; Gervy C; Clarke HJ; Demeestere I
Mol Hum Reprod; 2018 Apr; 24(4):221-232. PubMed ID: 29438534
[TBL] [Abstract][Full Text] [Related]
10. GnRH-analogues for ovarian protection in childhood cancer patients: how adult hypotheses are relevant in prepubertal females.
Osborne SE; Detti L
Curr Drug Targets; 2013 Jul; 14(8):856-63. PubMed ID: 23614679
[TBL] [Abstract][Full Text] [Related]
11. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.
Blumenfeld Z
Oncologist; 2007 Sep; 12(9):1044-54. PubMed ID: 17914074
[TBL] [Abstract][Full Text] [Related]
12. Combination of gonadotropin-releasing hormone (GnRH) agonists with GnRH antagonists before chemotherapy reduce but does not completely prevent a follicle-stimulating hormone flare-up.
von Wolff M; Kämmerer U; Kollmann Z; Santi A; Dietl J; Frambach T
Fertil Steril; 2011 Jan; 95(1):452-4. PubMed ID: 20869706
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-Releasing Hormone Analogs for Gonadal Protection During Gonadotoxic Chemotherapy: A Systematic Review and Meta-Analysis.
Sofiyeva N; Siepmann T; Barlinn K; Seli E; Ata B
Reprod Sci; 2019 Jul; 26(7):939-953. PubMed ID: 30270741
[TBL] [Abstract][Full Text] [Related]
14. Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.
Li X; Kang X; Deng Q; Cai J; Wang Z
Reprod Biol Endocrinol; 2013 Mar; 11():16. PubMed ID: 23452939
[TBL] [Abstract][Full Text] [Related]
15. Controversies over the use of GnRH agonists for reduction of chemotherapy-induced gonadotoxicity.
Garrido-Oyarzún MF; Castelo-Branco C
Climacteric; 2016 Dec; 19(6):522-525. PubMed ID: 27644002
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis.
Vitek WS; Shayne M; Hoeger K; Han Y; Messing S; Fung C
Fertil Steril; 2014 Sep; 102(3):808-815.e1. PubMed ID: 25044080
[TBL] [Abstract][Full Text] [Related]
17. [Fertility and fertility preservation in women].
Dittrich R; Lotz L
Dermatologie (Heidelb); 2023 Jul; 74(7):481-489. PubMed ID: 37289206
[TBL] [Abstract][Full Text] [Related]
18. Fertility status of Hodgkin lymphoma patients treated with chemotherapy and adjuvant gonadotropin-releasing hormone analogues.
Huser M; Smardova L; Janku P; Crha I; Zakova J; Stourac P; Jarkovsky J; Mayer J; Ventruba P
J Assist Reprod Genet; 2015 Aug; 32(8):1187-93. PubMed ID: 25724588
[TBL] [Abstract][Full Text] [Related]
19. Do cancer therapies damage the uterus and compromise fertility?
Griffiths MJ; Winship AL; Hutt KJ
Hum Reprod Update; 2020 Feb; 26(2):161-173. PubMed ID: 31863097
[TBL] [Abstract][Full Text] [Related]
20. Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists.
Hickman LC; Valentine LN; Falcone T
Am J Obstet Gynecol; 2016 Oct; 215(4):415-22. PubMed ID: 27422055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
